4.6 Editorial Material

Rewiring cancer cell death to enhance oncolytic viro-immunotherapy

Journal

ONCOIMMUNOLOGY
Volume 2, Issue 12, Pages -

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/onci.27138

Keywords

chemotherapy; danger-associated molecular patterns; immunogenic cell death; mitoxantrone; oncolytic virus

Ask authors/readers for more resources

Oncolytic viruses are novel immunotherapeutic agents that appear to mediate potent antineoplastic effects in both preclinical and clinical settings. Recent studies demonstrate that manipulating the mechanisms whereby cancer cells die in the course of oncolytic virotherapy has potential to boost anticancer immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available